Strategic Medical Affairs Director, Movement Disorders

Lundbeck; Boston (MA); On-site; USD 260,000 - 290,000; Full time

Benefits offered by this job

Bonus target

Health benefits

401k match

Flexible PTO

Job summary

Lundbeck is seeking a Medical Affairs Director for Movement Disorders to lead the US medical strategy, drive external engagement, and ensure scientific rigor across publications, congress activities, and medical content. The role partners with HEOR, Commercial, and Clinical Development to align medical initiatives with strategic goals.

The ideal candidate has 8+ years in rare disease or neurology contexts, strong KOL networks, and a track record in strategic publication planning and

Qualifications

• Accredited advanced scientific or clinical degree (MD, PharmD, PhD or MS).
• 5+ years of progressive, non-field-based Medical Affairs experience in pharma/biotech.
• 2+ years contributing to medical strategy, launch readiness, scientific communications, publication planning, and congress management.
• Experience designing/ed Medical Education programs (CME and non-CME).
• Knowledge of publication ethics and medical/regulatory review processes.

Responsibilities

• Provide expert medical perspective to co-create launch strategy with internal stakeholders.
• Support launch readiness, lifecycle planning, and integrated evidence generation strategies.
• Translate clinical data into actionable stakeholder engagement and brand planning.

Skills

Strategic leadership

Cross-functional collaboration

Scientific publication planning

KOL engagement

Data-driven decision making

Education

MD/PhD/PharmD/MS

Job description

Lundbeck is seeking a Medical Affairs Director for Movement Disorders to lead the US medical strategy, drive external engagement, and ensure scientific rigor across publications, congress activities, and medical content. The role partners with HEOR, Commercial, and Clinical Development to align medical initiatives with strategic goals.

The ideal candidate has 8+ years in rare disease or neurology contexts, strong KOL networks, and a track record in strategic publication planning and